Longevity & AgingClinical TrialPaywall

Resveratrol Supplement Tested Against Calorie Restriction for Metabolic Health Benefits

58-person trial compared resveratrol's effects to calorie restriction on insulin sensitivity, gene expression, and cardiovascular markers.

Saturday, March 28, 2026 0 views
Published in ClinicalTrials.gov
Clinical trial visualization: Resveratrol Supplement Tested Against Calorie Restriction for Metabolic Health Benefits

Summary

This Washington University trial investigated whether resveratrol supplements could mimic the well-documented health benefits of calorie restriction. Researchers enrolled 58 participants with obesity, metabolic syndrome, or diabetes to compare resveratrol supplementation against a 30% calorie-restricted diet and placebo. The study measured gene expression changes, cholesterol levels, insulin sensitivity, and cardiovascular health markers. Calorie restriction has proven longevity benefits in animal studies and metabolic improvements in humans. Resveratrol, found naturally in grape skins and red wine, shows promise in laboratory studies for enhancing fat metabolism and insulin function. This head-to-head comparison aimed to determine if resveratrol could deliver similar metabolic benefits without the challenge of sustained calorie restriction.

Detailed Summary

Washington University researchers conducted a groundbreaking comparison between resveratrol supplementation and calorie restriction to determine if this natural compound could replicate the metabolic benefits of eating fewer calories. The trial enrolled 58 participants with obesity, metabolic syndrome, or diabetes in a controlled study design.

Participants were randomly assigned to receive either Resvida resveratrol supplements, placebo, or follow a calorie restriction regimen reducing daily intake by 30% below standard recommendations. The 24-month study measured comprehensive metabolic markers including gene expression profiles, lipid panels, insulin sensitivity, and cardiovascular health indicators.

Calorie restriction has demonstrated remarkable longevity benefits in animal studies and significant metabolic improvements in humans, including enhanced insulin function and reduced disease risk. Resveratrol, naturally occurring in grape skins, red wine, peanuts, and mulberries, has shown similar promise in laboratory research for improving fat metabolism and potentially extending lifespan.

This direct comparison represents one of the first rigorous human trials testing whether resveratrol could serve as a "calorie restriction mimetic" - delivering similar health benefits without requiring the sustained dietary discipline that makes long-term calorie restriction challenging for most people.

The completed trial's findings could significantly impact longevity strategies by identifying whether supplementation offers a practical alternative to calorie restriction for metabolic health optimization. Understanding resveratrol's effects compared to proven interventions like calorie restriction provides crucial evidence for evidence-based longevity approaches and could influence clinical recommendations for metabolic health management.

Key Findings

  • First direct human comparison of resveratrol supplementation versus calorie restriction effects
  • Measured comprehensive metabolic markers including gene expression and insulin sensitivity
  • 58 participants with metabolic conditions followed for nearly two years
  • Tested whether resveratrol could mimic proven calorie restriction benefits
  • Evaluated practical alternative to challenging long-term calorie restriction

Methodology

Randomized controlled trial with 58 participants over 24 months. Participants were assigned to resveratrol supplementation, placebo, or 30% calorie restriction groups. Multiple metabolic and cardiovascular endpoints were measured.

Study Limitations

Relatively small sample size of 58 participants may limit statistical power. Results may not generalize beyond individuals with obesity, metabolic syndrome, or diabetes. Long-term safety and efficacy beyond 24 months remains unknown.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.